We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Innovative Medical Device Development Center Opens in NY

By HospiMedica International staff writers
Posted on 11 May 2016
Print article
Image: Vascular testing model produced on the Stratasys Objet500 Connex3 3D printer (Photo courtesy of the Jacobs Institute).
Image: Vascular testing model produced on the Stratasys Objet500 Connex3 3D printer (Photo courtesy of the Jacobs Institute).
Three-dimensional (3D) printer manufacturer Stratasys (Rehovot, Israel) and the Jacobs Institute (JI; Buffalo, NY, USA) have created a research and development (R&D) center aimed at using 3D printing to test and develop new medical devices.

The new Center of Excellence (COE) will leverage Stratasys’ 3D printing technology to develop and test new medical devices using printed prototypes and models. The COE will also serve as a referral center for hospitals and medical research organizations that are considering implementing 3D printing labs, and will enrich clinical education and training activities for a variety of audiences. It is also expected to aid hospitals and medical research groups in their own implementation of in-house 3D printing labs, an increasingly common phenomenon.

Stratasys supports the COE by providing advanced 3D printing solutions that feature a combination of vibrant colors and diverse material properties, including different levels of opacity and rigidity. Other partners in the COE will include Kaleida Health (Buffalo, NY, USA), the largest healthcare provider in Western New York, and the State University of New York at Buffalo (USA). Kaleida Health will participate via its vascular institute, while the University at Buffalo will share its Clinical and Translational Research Center (CTRC).

“By partnering with Stratasys, the Jacobs Institute is bringing the leader in 3D printing to Buffalo to work closely with the JI and its partners, Kaleida Health and the University at Buffalo, to accelerate the development of new medical technologies,” said Bill Maggio, CEO of the Jacobs Institute. “Working together, the respective institutions will leverage their strengths to make an impact far greater than they could make individually.”

“This announcement with the Jacobs Institute is an important milestone, marking the first time we are formally partnering with a medical organization to explore the exciting opportunities of 3D printing and healthcare,” said Scott Rader, general manager of medical solutions at Stratasys. “Stratasys brings decades of experience to the Jacobs Institute, a leader in 3D printed models, to push the boundaries of how these models can be used to train the next generation of physicians, and test new devices.”

Related Links:
Stratasys
Jacobs Institute
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
6 Drawer X-Tall Emergency Cart
UXRLU-333669-RED

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.